피하 피임 임플란트 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 호르몬 유형별, 작용 지속 기간별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Subdermal Contraceptive Implants Market size was valued at USD 1.2 Billion in 2024 and is poised to grow from USD 1.29 Billion in 2025 to USD 2.32 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global market for subdermal contraceptive implants, which deliver progestin to prevent pregnancy for up to three years, is gaining momentum as a low-maintenance and effective alternative to oral contraceptives. This innovation not only reduces unintended pregnancies but also lowers healthcare costs, appealing particularly in emerging economies where family planning programs are incorporating such technologies. The rising focus on long-acting reversible contraception is further driving demand for affordable solutions that minimize the need for repeat clinic visits. Additionally, as governments support national family planning initiatives, there's a notable trend towards implants due to their extended protection from a single insertion. Manufacturers are responding with advanced devices, paving the way for growth opportunities in adolescent health programs and remote healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Subdermal Contraceptive Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Subdermal Contraceptive Implants Market Segments Analysis

Global subdermal contraceptive implants market is segmented by product type, hormone type, duration of action, application, end user, distribution channel and region. Based on product type, the market is segmented into Single-Rod Contraceptive Implants and Two-Rod Contraceptive Implants. Based on hormone type, the market is segmented into Etonogestrel Implants, Levonorgestrel Implants and Others. Based on duration of action, the market is segmented into Up to 3 Years, 3-5 Years and Above 5 Years. Based on application, the market is segmented into Long-Acting Reversible Contraception (LARC), Family Planning and Birth Control. Based on end user, the market is segmented into Hospitals, Gynecology Clinics and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Government & Public Health Programs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Subdermal Contraceptive Implants Market

The global market for subdermal contraceptive implants is gaining momentum as healthcare providers increasingly endorse these options for their long-lasting effectiveness and low maintenance requirements, which boosts patient confidence in their use. Educational initiatives that emphasize the convenience of reversible, low-maintenance birth control are further promoting awareness and acceptance among various demographics. As women look for discreet and reliable contraceptive solutions, clinicians are more inclined to recommend implants during consultations, integrating them seamlessly into standard family planning practices. This synergy fosters enhanced patient adherence and bolsters provider reassurance, thereby creating a positive feedback loop that drives market growth.

Restraints in the Global Subdermal Contraceptive Implants Market

The global market for subdermal contraceptive implants faces significant restraints due to the varying regulatory pathways across different regions, which necessitate comprehensive clinical data to meet safety and efficacy standards. This inconsistency in submission requirements, coupled with prolonged review processes, can hinder market entry for new products, discouraging manufacturers from investing in their development. Moreover, shifting guidelines surrounding long-term hormonal exposure create additional uncertainty, compelling companies to invest extra resources into compliance monitoring. These challenges collectively restrict market growth by extending the time to revenue and inflating development costs, while negotiations among stakeholders often delay certifications, further impeding the swift adoption of innovative solutions.

Market Trends of the Global Subdermal Contraceptive Implants Market

The Global Subdermal Contraceptive Implants market is witnessing a notable trend toward digital health integration, which is transforming how reproductive health services are delivered. With the rising adoption of digital platforms, providers are now able to offer remote counseling and effective tracking of implant usage, enhancing patient adherence through personalized reminders and telehealth appointments. This technology-driven approach facilitates real-time data analytics, enabling manufacturers to optimize product design while simplifying reimbursement processes for insurers. The influx of such innovations is particularly beneficial in underserved areas, expanding market access and improving health outcomes for women globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Disease Epidemiology
• Technology Assessment

Global Subdermal Contraceptive Implants Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Single-Rod Contraceptive Implants
• Two-Rod Contraceptive Implants

Global Subdermal Contraceptive Implants Market Size by Hormone Type & CAGR (2026-2033)

• Market Overview
• Etonogestrel Implants
• Levonorgestrel Implants
• Others

Global Subdermal Contraceptive Implants Market Size by Duration of Action & CAGR (2026-2033)

• Market Overview
• Up to 3 Years
• 3-5 Years
• Above 5 Years

Global Subdermal Contraceptive Implants Market Size by Application & CAGR (2026-2033)

• Market Overview
• Long-Acting Reversible Contraception (LARC)
• Family Planning
• Birth Control

Global Subdermal Contraceptive Implants Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Gynecology Clinics
• Ambulatory Surgical Centers

Global Subdermal Contraceptive Implants Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Government & Public Health Programs

Global Subdermal Contraceptive Implants Market Size & CAGR (2026-2033)

• North America (Product Type, Hormone Type, Duration of Action, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Hormone Type, Duration of Action, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Hormone Type, Duration of Action, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Hormone Type, Duration of Action, Application, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Hormone Type, Duration of Action, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Dahua Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gedeon Richter Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theramex HQ UK Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratorios Ariston S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemo Research S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HRA Pharma SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Famy Care Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Sharp & Dohme (historical implant portfolio)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSPC Pharmaceutical Group Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurogine S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuqing Pharmaceutical Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations